Bausch + Lomb · 5 hours ago
Process Engineer II
Bausch + Lomb is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people. The Process Engineer II role involves developing manufacturing processes for new products and supporting ongoing improvements to existing processes and equipment.
Health CareHealth DiagnosticsMedical
Responsibilities
Perform process development and technology transfer for new products through design and execution of experimental and validation protocols
Perform manufacturing support improvement projects such as batch size scale-up, product hold time extensions, and other improvements to existing products
Participate in cross functional teams for project progression and investigation
Assist with capital expenditure projects
Liaison with Technical Services and MOB teams in the development and review of new and existing compounding/filling processes
Meets and maintains all required training during the year (SOP, EHS, and HR)
Support operational excellence and EHS initiatives
Assume responsibility for the GMP, ISO, EHS awareness and compliance within the respective area
Attend and participate in OpEx improvement initiatives such as reducing costs and OEE improvements
All other duties, as assigned
Qualification
Required
BS in Chemical/Mechanical Engineering or related field preferred
Previous leadership required
Strong engineering and manufacturing skills in a cGMP environment
Able to work quickly and under pressure
Good documentation, computer, and math skills
Must be detail oriented and quality conscious
Good team oriented and excellent communication skills
Must be able to read, write, and speak English
Preferred
Mechanical aptitude preferred
Company
Bausch + Lomb
We're a leading global eye health organization that is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life.
Funding
Current Stage
Public CompanyTotal Funding
$4.98BKey Investors
JP Morgan
2025-12-12Post Ipo Debt· $2.8B
2025-06-18Post Ipo Debt· $776.8M
2023-09-11Post Ipo Debt· $1.4B
Recent News
2026-01-03
Company data provided by crunchbase